| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |